rs1356450700
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The ENST00000617316.2(ORAI1):c.22C>G(p.Pro8Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,253,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P8S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000617316.2 missense
Scores
Clinical Significance
Conservation
Publications
- tubular aggregate myopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- myopathy, tubular aggregate, 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- combined immunodeficiency due to ORAI1 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Stormorken syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000617316.2. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150168Hom.: 0 Cov.: 30 show subpopulations
GnomAD4 exome AF: 0.0000408 AC: 45AN: 1103242Hom.: 0 Cov.: 29 AF XY: 0.0000435 AC XY: 23AN XY: 528474 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000266 AC: 4AN: 150168Hom.: 0 Cov.: 30 AF XY: 0.0000273 AC XY: 2AN XY: 73276 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at